243 filings
8-K
SNDX
Syndax Pharmaceuticals Inc
15 May 24
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
4:11pm
10-Q
2024 Q1
SNDX
Syndax Pharmaceuticals Inc
Quarterly report
8 May 24
7:04am
8-K
SNDX
Syndax Pharmaceuticals Inc
8 May 24
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
7:03am
ARS
2023 FY
SNDX
Syndax Pharmaceuticals Inc
2 Apr 24
Annual report to shareholders
4:30pm
DEFA14A
SNDX
Syndax Pharmaceuticals Inc
2 Apr 24
Additional proxy soliciting materials
4:02pm
8-K
fhl5p
18 Mar 24
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
7:10am
S-3ASR
lbbctprj
27 Feb 24
Automatic shelf registration
5:28pm
S-8
86di8uds 3ox4po9
27 Feb 24
Registration of securities for employees
5:21pm
8-K
cx0nw8q0d05
27 Feb 24
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
4:03pm
8-K
513h3n0
20 Dec 23
Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
8:40am
8-K
io7ko54k 94bau
15 Dec 23
Entry into a Material Definitive Agreement
5:29pm
424B5
ip381cj
15 Dec 23
Prospectus supplement for primary offering
5:29pm
424B5
hynjh
14 Dec 23
Prospectus supplement for primary offering
4:30pm
8-K
2wrcuvda
12 Dec 23
Other Events
4:05pm
UPLOAD
0yfso vxuq79vps9a
7 Dec 23
Letter from SEC
12:00am
CORRESP
uydyl6szlkfw9
28 Nov 23
Correspondence with SEC
12:00am
UPLOAD
plpw 3w470rtymjf
13 Nov 23
Letter from SEC
12:00am